Fever diagnostics: LMIC market analysis
New diagnostic products can often be stymied between product commercialization and in-country roll-out. This “valley of death” is a particular challenge in markets for infectious fever-related diseases that are not traditionally supported by global health donors. As part of our access strategy, we are working to help diagnostic solutions move from development and evidence generation into adoption, through key activities that support governments, suppliers, and partners to plan for product roll-out.
To this end, with partners at Advention, we have conducted a comprehensive fever market analysis, provided here as a resource for those planning to commercialize a new fever diagnostic in low- and middle-income country settings.
If you would like more information or to explore development of a product-specific analysis, please contact us.
financing & distribution mechanisms